Sector: Health Care
Director information for INTEGRA LIFESCIENCES HOLDINGS CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Barbara B. Hill | Operating Partner, NexPhase Capital | 73 | ["management experience","strategic and operational experience in the managed healthcare and pharmaceutical industries","compliance and manufacturing experience in the healthcare industry","experience serving on boards of other publicly traded companies"] | ["1","Compensation","Nominating and Corporate Governance (Chair)","Quality"] | 2026 |
| Christian S. Schade | Former President and CEO, Halda Therapeutics LLC; Former Chief Executive Officer | 65 | ["Wealth of corporate management, finance, manufacturing, accounting, human resources, business development and risk management skills","Significant knowledge and experience in the life sciences industry","Held several senior leadership positions at both private and public companies","Experience serving on the boards of other public companies"] | ["Audit (Chair)","Finance (Chair)"] | 2026 |
| Dr. Essig | Non-Executive Chairman | [] | ["Audit Committee","Compensation Committee","Nominating and Corporate Governance Committee","Finance Committee","Quality Committee"] | 2026 | |
| Harvinder Singh | Executive Vice President and President, International Business | 58 | ["20 years at Abbott Laboratories","corporate officer and vice president of global commercial operations for the vascular business","sales, marketing, strategy and general management roles","experience in India, Hong Kong, Shanghai, Tokyo, Singapore, and the United States","bachelor’s degree in chemistry and biology from Punjab University","M.B.A. from University of Indore, India","alumnus of Harvard Business School’s Advanced Management Program"] | ["APACMed","American Medical Devices and Diagnostics Manufacturers’ Association"] | 2026 |
| Jeffrey A. Graves, Ph.D. | President and CEO, 3D Systems Corporation | 64 | ["management experience","strategic experience","operational experience","financial experience","perspective on strategy and growth"] | ["1","Compensation","Nominating and Corporate Governance","Quality"] | 2026 |
| Keith Bradley, Ph.D. | Retired Professor of International Management and Management Strategy, Open University and Cass Business School, U.K.; Former Professor of International Management & Management Strategy | 81 | ["Retired Professor of International Management","Management Strategy","international experience","extensive business experience in the healthcare and medical device industries","financial literacy","more than 30 years of service on the boards of publicly traded companies"] | ["Nominating and Corporate Governance","Audit","Finance"] | 2026 |
| Lea Knight | Executive Vice President and Chief Financial Officer (CFO) | 54 | ["Over 18 years at Johnson & Johnson in financial roles","Chief Financial Officer of Johnson and Johnson’s North America pharmaceuticals business","Executive Vice President of Business Finance for Booz Allen Hamilton","Managed audit engagements at Arthur Andersen LLP","Certified public accountant licensed in Pennsylvania","Undergraduate degree in accounting from the University of Virginia","M.B.A. in finance and strategic management from the Wharton School, University of Pennsylvania"] | ["Board Trustee of Thomas Jefferson University and Health System","Philadelphia Forum of Executive Women","Former member and chair of the board of directors for the Public Interest Law Center"] | 2026 |
| Mojdeh Poul | President and Chief Executive Officer and Director; President and Chief Executive Officer (CEO) | 63 | ["President and CEO, Integra LifeSciences Holdings Corporation","over 30 years of executive management experience in the Healthcare/MedTech industry","history of success in development and execution of corporate strategy","business transformation","portfolio management","innovation","extensive skills and experience in global business operations","P&L management","marketing","government relations"] | ["1","audit committee"] | 2026 |
| Renee W. Lo | Vice President APAC, LinkedIn Corporation; Vice President APAC, Sales Solutions | 45 | ["Leading the commercial organization for sales and marketing efforts in Asia Pacific","Partner CTO, APAC Regional Director for Google","General manager for Microsoft, leading its data and artificial intelligence business in Asia","Built regional technology teams at Amazon Web Services","Ran global business development for Amazon.com","More than 13 years of experience in North America","Leadership roles within product development, commercial, operations, business and corporate strategy"] | ["Compensation (Chair)"] | 2026 |
| Shaundra D. Clay | Former Global Vice President, Finance, Beam Suntory | 55 | ["Former Global Vice President, Finance","Corporate executive","Finance","Healthcare","International business","Finance expertise","Healthcare expertise","Global business management","Risk assessment"] | ["Audit","Finance"] | 2026 |
| Stuart M. Essig, Ph.D. | Former Executive Chairman; Chairman of the Board | 64 | ["Managing Director, Prettybrook Partners, LLC","broad experience in the medical device and healthcare industries","executive management and oversight","international business","manufacturing","finance","accounting fields","service on the boards of publicly traded companies for over 30 years","extensive knowledge of the health care industry"] | ["2","Quality"] | 2026 |
